Showing 1,061 - 1,080 results of 8,597 for search 'effective dysfunction', query time: 0.14s Refine Results
  1. 1061

    Dysregulation of protein degradation and alteration of secretome in α-synuclein-exposed astrocytes: implications for dopaminergic neuronal dysfunction by Aishwarya Raj, Roon Banerjee, Vikram Holla, Nitish Kamble, Ravi Yadav, Pramod Kumar Pal, Indrani Datta

    Published 2024-12-01
    “…Additionally, we explored the effect of astrocytic secretome on dopaminergic-neuronal survival, neurite collapse and function. …”
    Get full text
    Article
  2. 1062

    Comparative prospective study of biofeedback therapy and neuromuscular electrical stimulation in rehabilitation of patients with pelvic floor dysfunctions by V. A. Krutova, A. V. Nadtochy

    Published 2019-09-01
    “…Aim. To evaluate the effectiveness of the combined effects of biological feedback (BFB therapy) and electroimpulse stimulation (EIS) in rehabilitation of patients with pelvic floor dysfunctions. …”
    Get full text
    Article
  3. 1063

    ENDOCRINE ASPECTS OF AMIODARONE THERAPY IN CLINICAL PRACTICE (FOLLOW-UP AND TREATMENT ALGORITHM FOR PATIENTS WITH THYROID DYSFUNCTION) by N. Yu. Sviridenko, N. M. Platonova, N. V. Molashenko, S. P. Golitsyn, S. A. Bakalov, S. E. Serdyuk

    Published 2012-04-01
    “…This review discusses the effects of amiodarone on thyroid function and summarises the results of international studies and the evidence obtained by the researchers from the A.L. …”
    Get full text
    Article
  4. 1064

    A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease by Michelle Thuy Nguyen, Andrew Lian, Frederick Timothy Guilford, Vishwanath Venketaraman

    Published 2025-03-01
    “…Non-alcoholic fatty liver disease (NAFLD) is a global cause of liver dysfunction. This spectrum of hepatic disorders can progress to severe conditions, such as non-alcoholic steatohepatitis (NASH) and cirrhosis, due to oxidative stress and sustained cellular injury. …”
    Get full text
    Article
  5. 1065

    Iron overload and oxidative stress participated in zinc oxide nanoparticles-induced blood-brain barrier dysfunction by Eun-Hye Kim, Seung Mi Baek, Donghyun Kim, Sungbin Choi, Wondong Kim, Yiying Bian, Soroush Tahmasebi, Ok-Nam Bae

    Published 2025-08-01
    “…Increased oxidative stress led to lysosomal dysfunction and cytotoxicity in bEnd cells treated with ZnO-NPs.3 cells. …”
    Get full text
    Article
  6. 1066

    Multi-omics reveal the neuroprotective mechanisms of Xinshubao tablet against scopolamine-induced cognitive dysfunction in mice by Zhe Yang, Zhe Yang, Feng-Rong Zhang, Lu Ren, Jia-Ming Bai, Shi-Cong Wang, Xian-Yu Li, Hong-Jun Yang, Hong-He Xiao

    Published 2025-07-01
    “…Transformation of XSB derived fecal microbiota (XSB-FM) effectively alleviated cognitive dysfunction and intestinal barrier injures. …”
    Get full text
    Article
  7. 1067

    Biological ageing mediates the associations between urinary metals and metabolic dysfunction-associated steatotic liver disease by Yin-Ping Wu, Jin Feng, Yuan-Yuan Zhang, Bai-Yun Wu, Ze-Hua Zhao, Yu-Chen Fan

    Published 2025-07-01
    “…Metabolic dysfunction-associated steatotic liver disease (MASLD), which is associated with exposure to heavy metals in the environment, poses a considerable public health challenge globally. …”
    Get full text
    Article
  8. 1068

    Thyroid dysfunction as a long-term post-COVID-19 complication in mild-to-moderate COVID-19 by Vesselina Yanachkova, Teodora Stankova, Radiana Staynova

    Published 2023-03-01
    “…The aim of the present study was to assess the post-COVID-19 effects on thyroid function in patients without history of thyroid disease after complete recovery from mild-to-moderate COVID-19. …”
    Get full text
    Article
  9. 1069

    Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy by Jie‐hong Wu, Ya‐nan Li, An‐qi Chen, Can‐dong Hong, Chun‐lin Zhang, Hai‐ling Wang, Yi‐fan Zhou, Peng‐Cheng Li, Yong Wang, Ling Mao, Yuan‐peng Xia, Quan‐wei He, Hui‐juan Jin, Zhen‐yu Yue, Bo Hu

    Published 2020-01-01
    “…Moreover, anti‐Sema4D had a therapeutic advantage over anti‐VEGF on pericyte dysfunction. Anti‐Sema4D and anti‐VEGF also conferred a synergistic therapeutic effect in two DR models. …”
    Get full text
    Article
  10. 1070
  11. 1071

    O-prenylchalcones inhibit cell proliferation and activate apoptosis by inducing mitochondrial dysfunction in gastric cancer cells by José C. Espinoza-Hicks, Yarely M. Salinas-Vera, Javier Camarillo-Cisneros, Alejandro A. Camacho-Dávila, Jessica L. Hernández-Rivera, Nadia Flores-Huerta, Eloisa Ibarra-Sierra, Carlos Pérez-Plasencia, María Elizbeth Álvarez-Sánchez, Ángeles C. Tecalco-Cruz, César López-Camarillo

    Published 2025-07-01
    “…Chalcones are favoured molecules from the perspective of chemical medicine, as they exhibit efficient antitumour effects in various human diseases. In the present study, we investigated the anticancer effects of 11 novel synthetic O-prenylchalcones on AGS gastric cancer cells. …”
    Get full text
    Article
  12. 1072
  13. 1073

    Blood metabolites as mediators in erectile dysfunction: insights from a multi-center proteomics and genetic study by Junhao Chen, Junxian Zhao, Zhi Zhang, Xingcheng Zhu, Jieming Zuo, Zuqing Nie, Yuanzhi Fu, Haifeng Wang, Mengjun Tang, Shi Fu

    Published 2025-06-01
    “…A large-scale two-sample MR analysis, including coloc colocalization analysis and SMR (Summary data-based Mendelian Randomization) analysis, was conducted to evaluate the reliability of proteomic effects on ED outcomes. Additionally, MR mediation analysis involving 1,400 blood metabolites was performed to investigate how these proteins mediate the effect of blood metabolites on ED. …”
    Get full text
    Article
  14. 1074

    GDF11 protects against mitochondrial-dysfunction-dependent NLRP3 inflammasome activation to attenuate osteoarthritis by Pengfei Zhang, Haoxin Zhai, Shuai Zhang, Xiaojie Ma, Ao Gong, Zhaoning Xu, Wei Zhao, Hui Song, Shufeng Li, Tengfei Zheng, Zhendong Ying, Lei Cheng, Yunpeng Zhao, Lei Zhang

    Published 2025-07-01
    “…Furthermore, loss of GDF11 led to NLRP3 inflammasome activation, inflammation, and metabolic dysfunction. In an in vivo surgically induced mouse model, intraarticular administration of recombinant human GDF11 alleviated OA pathogenesis, whereas GDF11 conditional knockout reversed this effect. …”
    Get full text
    Article
  15. 1075
  16. 1076

    The Hepatoprotective Properties of Gentiopicroside, Sweroside, and Swertiamarin Against Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Anthony O. Boateng, Vinood B. Patel, S. W. Annie Bligh

    Published 2025-05-01
    “…Metabolic dysfunction-associated steatotic liver disease (MASLD) is a metabolic disease characterised by the accumulation of fat in the liver. …”
    Get full text
    Article
  17. 1077

    Dexmedetomidine Reduced Cytokine Release during Postpartum Bleeding-Induced Multiple Organ Dysfunction Syndrome in Rats by Liu Xianbao, Zhan Hong, Zeng Xu, Zhang Chunfang, Chen Dunjin

    Published 2013-01-01
    “…In the present study, the effects of DEX on postpartum bleeding-induced multiple organ dysfunction syndrome (BMODS) were studied in rats in which BMODS was induced by the combination of hypotension and clamping of the superior mesenteric artery. …”
    Get full text
    Article
  18. 1078

    Dose determination of VV116 in COVID-19 patients with severe liver dysfunction: a case report by Jing Yang, Wenwen Jiang, Jianqing Deng, Min Liu, Ya Xue, Jizhang Bao, Tingting Jia, Qi Hu, Lichao Zhang

    Published 2025-02-01
    “…Finally, the patient’s viral load rapidly dropped to an undetected level, and no drug-related adverse effects were observed.…”
    Get full text
    Article
  19. 1079

    Rescuing vascular dysfunction in dorsal pancreatic arteries prevents tacrolimus-induced glucose metabolism disorder in mice by Lingyan Fei, Honghong Wang, Dongliang Zhao, Xiaohua Wang, Jizhen Ren, Lanyun Liu, Chun Tang, Yan Lei, Qingqing Wang, Yuanpeng Nie, Yang Liu, Na Li, Ming Zhong, Nan Xu, Jin Wei, Pontus B. Persson, Andraes Patzak, Pratik H. Khedkar, Zhihua Zheng, Shan Jiang

    Published 2025-06-01
    “…Furthermore, treatment with Tac led to vascular dysfunction in pancreatic arteries. All of these adverse effects could be partially or fully abrogated by valsartan. …”
    Get full text
    Article
  20. 1080

    SETD7 drives diabetic endothelial dysfunction through FBXO45-mediated GPX4 ubiquitylation by Wen Zhong, Ruoxue Chen, Jialin Zhao, Yuyu Zhang, Jintao He, Huibin Wang, Feng Zhu, Chunxiang Fan, Xinhua Liu

    Published 2025-04-01
    “…However, its function in the context of diabetic endothelial dysfunction remains poorly understood. This study aims to elucidate the involvement and underlying mechanisms of SETD7 in diabetic endothelial dysfunction. …”
    Get full text
    Article